NC-stat® DPNCheck&#8482 device addresses unmet medical need

Initiates Campaign of Investor Outreach to Strengthen Company Awareness

Philadelphia, Pennsylvania May 23-27, 2012

Importance of Managed Care Sector is Highlighted

NeuroMetrix Announces WellMed Medical Management’s Integration of NC-stat® DPNCheck™ Into Their Patient Evaluation Program WALTHAM, Mass. --(BUSINESS WIRE)--May. 15, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the

Malvern (U.K.) Diabetic Foot Conference on May 9-12, 2012

Business Focus on Diabetes-Related Nerve Damage

Operational and Strategic Progress in Diabetes Business

Investigating the Impact of Intensive Diabetes Management on Diabetic Peripheral Neuropathy

NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device WALTHAM, Mass., Apr 18, 2012 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it has filed a premarket